Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$1.17 USD
-0.11 (-8.59%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $1.16 -0.01 (-0.85%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.20 | 0.00% |
Earnings Summary
For their last quarter, Lyell Immunopharma (LYEL) reported earnings of -$0.18 per share, beating the Zacks Consensus Estimate of $-0.20 per share. This reflects a positive earnings surprise of 10.00%. Look out for LYEL's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for LYEL
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
LYEL: What are Zacks experts saying now?
Zacks Private Portfolio Services